-+ 0.00%
-+ 0.00%
-+ 0.00%

NEUROSENSE CONFIRMS FAVORABLE SAFETY AND TOLERABILITY OF PRIMEC IN AN ALZHEIMER'S PHASE 2 STUDY

Reuters·12/22/2025 14:19:39

Please log in to view news